• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤转移过程中的免疫逃逸机制。

Tumor immune escape mechanisms that operate during metastasis.

机构信息

Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires C1428, Argentina.

出版信息

Curr Pharm Biotechnol. 2011 Nov;12(11):1923-36. doi: 10.2174/138920111798376987.

DOI:10.2174/138920111798376987
PMID:21470132
Abstract

Immune cells actively influence, among other factors, each step of tumor development determining the chance of a cancer cell to survive in a threaten microenvironment. Antitumor immune-mediated mechanisms are activated as soon as the first cancer cell is detected and operate both during primary tumor formation and during metastasis. However, when both innate and adaptive immunity becomes impaired, tumor development occurs. In this sense, compelling evidences indicate that tumor cells employ mechanisms that circumvent or thwart the immune response to enhance their own growth. These mechanisms include the secretion of immunosuppressive factors and the induction of distinct regulatory lymphoid or myeloid cells and, as occur with the immune response, they operate both during primary tumor formation and metastasis. Interestingly, cellular and molecular mechanisms of the immune response are important components of the tumor microenvironment and have the ability to promote or suppress tumor progression depending of the context of each cell interaction. In that sense, researchers are focusing their attention in the study of the influence of the tumor microenvironment in tumor growth and metastasis to better understand cancer biology and to formulate novel therapeutic approach. This review will focus on the present knowledge about interaction between immune cells and tumors in the context of metastasis, discussing the participation of different components of innate and adaptive immune response in the process of metastasis formation and dissemination.

摘要

免疫细胞积极影响肿瘤发展的每一个步骤,这些影响因素包括肿瘤微环境等,从而决定癌细胞在受到威胁的微环境中存活的机会。一旦第一个癌细胞被检测到,抗肿瘤免疫介导的机制就会被激活,并且在原发性肿瘤形成和转移过程中都起作用。然而,当先天免疫和适应性免疫都受损时,肿瘤就会发展。从这个意义上说,有强有力的证据表明,肿瘤细胞采用了规避或破坏免疫反应的机制来促进自身生长。这些机制包括分泌免疫抑制因子和诱导不同的调节性淋巴或髓样细胞,并且与免疫反应一样,它们在原发性肿瘤形成和转移过程中都起作用。有趣的是,免疫反应的细胞和分子机制是肿瘤微环境的重要组成部分,并且能够根据每个细胞相互作用的情况促进或抑制肿瘤的进展。在这种意义上,研究人员正在关注肿瘤微环境对肿瘤生长和转移的影响的研究,以更好地了解癌症生物学并制定新的治疗方法。这篇综述将重点讨论在转移背景下免疫细胞与肿瘤之间相互作用的现有知识,讨论固有和适应性免疫反应的不同成分在转移形成和传播过程中的参与。

相似文献

1
Tumor immune escape mechanisms that operate during metastasis.肿瘤转移过程中的免疫逃逸机制。
Curr Pharm Biotechnol. 2011 Nov;12(11):1923-36. doi: 10.2174/138920111798376987.
2
Immunosuppressive cells in tumor immune escape and metastasis.肿瘤免疫逃逸和转移中的免疫抑制细胞。
J Mol Med (Berl). 2016 May;94(5):509-22. doi: 10.1007/s00109-015-1376-x. Epub 2015 Dec 22.
3
The complexity of immune evasion mechanisms throughout the metastatic cascade.免疫逃避机制在转移级联反应中的复杂性。
Nat Immunol. 2024 Oct;25(10):1793-1808. doi: 10.1038/s41590-024-01960-4. Epub 2024 Sep 16.
4
Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art.癌症衍生的外泌体微小RNA塑造肿瘤微环境中的免疫系统:最新进展
Semin Cell Dev Biol. 2017 Jul;67:23-28. doi: 10.1016/j.semcdb.2016.12.004. Epub 2016 Dec 9.
5
Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy.髓系细胞作为肿瘤微环境的协调者:纳米颗粒癌症治疗的新靶点。
Nanomedicine (Lond). 2016 Oct;11(20):2735-2751. doi: 10.2217/nnm-2016-0208. Epub 2016 Sep 23.
6
Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms.肿瘤微环境将浆细胞样树突状细胞转化为免疫抑制/耐受细胞:分子机制的见解。
J Leukoc Biol. 2013 Mar;93(3):343-52. doi: 10.1189/jlb.0812397. Epub 2012 Nov 7.
7
Immunosuppressive strategies that are mediated by tumor cells.由肿瘤细胞介导的免疫抑制策略。
Annu Rev Immunol. 2007;25:267-96. doi: 10.1146/annurev.immunol.25.022106.141609.
8
Myeloid regulatory cells in tumor spreading and metastasis.肿瘤扩散和转移中的髓系调节细胞。
Immunobiology. 2015 Feb;220(2):236-42. doi: 10.1016/j.imbio.2014.07.017. Epub 2014 Jul 23.
9
Eph Receptors in the Immunosuppressive Tumor Microenvironment.Eph 受体在免疫抑制性肿瘤微环境中的作用。
Cancer Res. 2021 Feb 15;81(4):801-805. doi: 10.1158/0008-5472.CAN-20-3047. Epub 2020 Nov 11.
10
Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells.肿瘤微环境中的免疫抑制:树突状细胞介导的 T 细胞耐受作用。
Cancer Immunol Immunother. 2012 Feb;61(2):289-293. doi: 10.1007/s00262-011-1181-5. Epub 2012 Jan 12.

引用本文的文献

1
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.靶向纳米药物重塑免疫抑制性肿瘤微环境以增强癌症免疫治疗。
Acta Pharm Sin B. 2022 Dec;12(12):4327-4347. doi: 10.1016/j.apsb.2022.11.001. Epub 2022 Nov 4.
2
Eukaryotic Extension Factor 2 Kinase may Affect the Occurrence and Development of Glioblastoma Through Immune Cell Infiltration.真核延伸因子 2 激酶可能通过免疫细胞浸润影响胶质母细胞瘤的发生和发展。
Neurochem Res. 2022 Dec;47(12):3670-3681. doi: 10.1007/s11064-022-03679-w. Epub 2022 Jul 18.
3
Site-specific metastasis: A cooperation between cancer cells and the metastatic microenvironment.
肿瘤特异性转移:癌细胞与转移微环境的合作。
Int J Cancer. 2021 Mar 15;148(6):1308-1322. doi: 10.1002/ijc.33247. Epub 2020 Aug 27.
4
Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells.多西他赛耐药前列腺癌细胞生物标志物的鉴定、特征及其功能
Oncol Lett. 2019 Sep;18(3):3236-3248. doi: 10.3892/ol.2019.10623. Epub 2019 Jul 16.
5
Differential role of intravenous anesthetics in colorectal cancer progression: implications for clinical application.静脉麻醉剂在结直肠癌进展中的差异作用:对临床应用的启示。
Oncotarget. 2016 Nov 22;7(47):77087-77095. doi: 10.18632/oncotarget.12800.
6
Update on the challenges and recent advances in cancer immunotherapy.癌症免疫疗法的挑战与近期进展综述
Immunotargets Ther. 2013 Jun 15;2:39-49. doi: 10.2147/ITT.S30818. eCollection 2013.
7
The current status of checkpoint inhibitors in metastatic bladder cancer.检查点抑制剂在转移性膀胱癌中的现状
Clin Exp Metastasis. 2016 Oct;33(7):629-35. doi: 10.1007/s10585-016-9807-9. Epub 2016 Jul 5.
8
Circulating tumor-associated neutrophils (cTAN) contribute to circulating tumor cell survival by suppressing peripheral leukocyte activation.循环肿瘤相关中性粒细胞(cTAN)通过抑制外周白细胞激活来促进循环肿瘤细胞的存活。
Tumour Biol. 2016 Apr;37(4):5397-404. doi: 10.1007/s13277-015-4349-3. Epub 2015 Nov 12.
9
E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation.E2F1 通过调节 NF-κB 使前列腺癌细胞对 ICAM-1 介导的抗肿瘤免疫产生抗性。
Mol Cancer. 2014 Apr 17;13:84. doi: 10.1186/1476-4598-13-84.
10
Bioengineering embryonic stem cell microenvironments for the study of breast cancer.用于乳腺癌研究的生物工程化胚胎干细胞微环境
Int J Mol Sci. 2011;12(11):7662-91. doi: 10.3390/ijms12117662. Epub 2011 Nov 8.